Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD



Rating:

Share or cite this content

Citations should be made in the following way:
R. Lundgren (Stockholm, Sweden), K. Andelid (Göteborg, Sweden), M. Ezerskyte (Stockholm, Sweden), N. Pournaras (Stockholm, Sweden), B. Brundin (Stockholm, Sweden), K. Che (Stockholm, Sweden), A. Linden (Stockholm, Sweden). Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis. 3829

Member's Comments

No comment yet.

Related content which might interest you: Chronic bronchitis affects mortality in smokers with and without COPD Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Defining the contribution of emphysema and chronic bronchitis in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Endocrinopathies and related with COPD exacerbation Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Chronic obstructive pulmonary disease in smokers with asthma Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission Year: 2011 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001 The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study Source: Eur Respir J 2012; 40: 28-36 Year: 2012 Calorie-intake in patients hospitalized for an acute COPD exacerbation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013